These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 15150305)

  • 1. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
    Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment.
    Jones RM; Mongin SJ; Lazovich D; Church TR; Yeazel MW
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):777-84. PubMed ID: 18381476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy.
    Scheitel SM; Ahlquist DA; Wollan PC; Hagen PT; Silverstein MD
    Mayo Clin Proc; 1999 Dec; 74(12):1207-13. PubMed ID: 10593348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
    Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
    Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.
    Miglioretti DL; Rutter CM; Bradford SC; Zauber AG; Kessler LG; Feuer EJ; Grossman DC
    Med Care; 2008 Sep; 46(9 Suppl 1):S91-6. PubMed ID: 18725839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.
    Giorgi Rossi P; Grazzini G; Anti M; Baiocchi D; Barca A; Bellardini P; Brezzi S; Camilloni L; Falini P; Maccallini V; Mantellini P; Romeo D; Rubeca T; Venditti MA
    J Med Screen; 2011; 18(3):121-7. PubMed ID: 22045820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of mailing fecal occult blood test kits on return rate in a community cancer screening center.
    Mahon SM
    Oncol Nurs Forum; 1995 Sep; 22(8):1259-63. PubMed ID: 8532551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A national survey of primary care physicians' methods for screening for fecal occult blood.
    Nadel MR; Shapiro JA; Klabunde CN; Seeff LC; Uhler R; Smith RA; Ransohoff DF
    Ann Intern Med; 2005 Jan; 142(2):86-94. PubMed ID: 15657156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings.
    Myers RE; Turner B; Weinberg D; Hauck WW; Hyslop T; Brigham T; Rothermel T; Grana J; Schlackman N
    Prev Med; 2001 Oct; 33(4):249-60. PubMed ID: 11570828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and validity of a questionnaire to measure colorectal cancer screening behaviors: does mode of survey administration matter?
    Vernon SW; Tiro JA; Vojvodic RW; Coan S; Diamond PM; Greisinger A; Fernandez ME
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):758-67. PubMed ID: 18381467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    JMIR Mhealth Uhealth; 2019 Feb; 7(2):e11114. PubMed ID: 30720439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer screening before and after switching to a high-deductible health plan.
    Wharam JF; Galbraith AA; Kleinman KP; Soumerai SB; Ross-Degnan D; Landon BE
    Ann Intern Med; 2008 May; 148(9):647-55. PubMed ID: 18458277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial.
    Sequist TD; Zaslavsky AM; Marshall R; Fletcher RH; Ayanian JZ
    Arch Intern Med; 2009 Feb; 169(4):364-71. PubMed ID: 19237720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.
    Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Schneede J; Tveit KM; Hoff G
    JAMA; 2014 Aug; 312(6):606-15. PubMed ID: 25117129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer screening in LHU4 Chiavarese, Italy: ethical, methodological and outcome evaluations at the end of the first round.
    Ferrari Bravo M; De Conca V; Devoto GL; Sironi M; Mele R; Fumagalli A; Rimassa P; Rossi G; Zampogna A; Sticchi C; Gabutti G;
    J Prev Med Hyg; 2012 Mar; 53(1):37-43. PubMed ID: 22803318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Program to improve colorectal cancer screening in a low-income, racially diverse population: a randomized controlled trial.
    Jean-Jacques M; Kaleba EO; Gatta JL; Gracia G; Ryan ER; Choucair BN
    Ann Fam Med; 2012; 10(5):412-7. PubMed ID: 22966104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.